Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07090564 · ClinicalTrials.gov registry record
Treatment Outcomes in PASC Patients With Neurocognitive Impairment
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 171
- Enrollment target
NCT07090564 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 171 participants.
The verdict
NCT07090564 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
Study Summary
Longitudinal study collecting retrospective and prospective data on treatments received and change in quality of life among patients with neurocognitive symptoms attending a Long COVID clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2024-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07090564
The ClinicalTrials.gov registry entry for NCT07090564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07090564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07090564 about?
NCT07090564 is a clinical study titled "Treatment Outcomes in PASC Patients With Neurocognitive Impairment". Longitudinal study collecting retrospective and prospective data on treatments received and change in quality of life among patients with neurocognitive symptoms attending a Long COVID clinic
What is the current status of trial NCT07090564?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2022-10-12. Estimated completion is 2024-04-01.
Who is sponsoring clinical trial NCT07090564?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.